XLXin Li

Xin Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xin Li has a total of 247 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaoshuang Xia

    Department of Neurology, the Second Hospital of Tianjin Medical University, Tianjin, China

    42 shared publications
  • Lin Wang

    Tianjin Interdisciplinary Innovation Centre for Health and Meteorology, Tianjin, China; Department of Geriatrics, The Second Hospital of Tianjin Medical University, Tianjin, China

    34 shared publications
  • Yumeng Gu

    Department of Neurology, the Second Hospital of Tianjin Medical University, Tianjin, China

    17 shared publications
  • Juanjuan Xue

    Department of Neurology, the Second Hospital of Tianjin Medical University, Tianjin, China

    13 shared publications
  • Peilin Liu

    Department of Neurology, the Second Hospital of Tianjin Medical University, Tianjin, China

    11 shared publications
  • Zhuangzhuang Chen

    Department of Neurology, the Second Hospital of Tianjin Medical University, Tianjin, China

    9 shared publications

Latest Publications

  • Open Access

    Association of homocysteine and waist-to-height ratio with poor sleep quality in community-dwelling individuals at high risk of stroke: a cross-sectional study based on two community screening rounds in 2015 and 2025

    by AiJia Liu, XiaoLin Tian, JuanJuan Xue, Yu Yan, Xin Li

    Background: Poor sleep quality has been associated with cerebrovascular disease and is increasingly recognised as a potentially modifiable factor relevant to cerebrovascular health. Nevertheless, the prevalence of sleep problems and their metabolic-related factors among community-dwelling individuals at high risk of stroke remains under-researched. Homocysteine (Hcy) and waist-to-height ratio (WHtR) are related to vascular health and central adiposity, respectively, but their associations with poor sleep quality in this population remain insufficiently understood. Based on two community-based cross-sectional screening datasets from 2015 to 2025, this study aims to describe the prevalence of poor sleep quality in this population and to specifically investigate the association between Hcy and WHtR and poor sleep quality. Methods: This study enrolled community-dwelling individuals at high risk of stroke in 2015 ( n = 402) and 2025 ( n = 430). Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), with a PSQI score > 5 defined as poor sleep quality. A pooled cohort ( n = 689) was constructed after excluding duplicate individuals from the two screening rounds, and trends in the associations of Hcy and WHtR with poor sleep quality were further examined. Results: The prevalence of poor sleep quality was 52.7% in 2015 and 57.4% in 2025. In separate multivariable logistic regression analyses, Hcy and WHtR were consistently associated with poor sleep quality in both screening cohorts ( P < 0.05). In the pooled cohort, each 1 µmol/L increase in Hcy was associated with 15.3% higher odds of poor sleep quality (OR = 1.153, 95% CI: 1.102–1.207, P < 0.001), while each 0.1-unit increase in WHtR was associated with 151.6% higher odds (OR = 2.516, 95% CI: 1.800–3.518, P < 0.001). Significant positive trends were observed across Hcy tertiles ( P for trend = 0.002) and WHtR tertiles ( P for trend = 0.001). Conclusion: Higher Hcy levels and WHtR were consistently associated with greater odds of poor sleep quality across the two screening cohorts, with significant positive trends observed in the pooled analysis.

  • Open Access

    Single-cell profiling defines cellular ecosystems and malignant cell state coupling across pan-cancer tumor microenvironments

    by Xiaoxiao Yang, Yang Tong, Yuting Wang, Peng Xie, Xin Li, Jiapei Yuan, Yang Yang

  • Open Access

    Native Platelet Function and Clinical Outcomes in Very Elderly Patients: A Retrospective Cohort Study

    by Nanzhu Yang, Xiuyuan Zhao, Xin Li

    This study examined native platelet function in very elderly patients (≥80 years) not receiving antiplatelet or anticoagulant therapy, its correlation with routine laboratory parameters, and factors associated with poor 90-day outcomes. This retrospective cohort study included 94 very elderly inpatients (80–89 years, n=50; ≥90 years, n=44). Patients on antiplatelet, anticoagulant, or glucocorticoid therapy within 7 days before admission were excluded. Baseline data, laboratory parameters—including ADP‑ and AA‑induced aggregation, platelet count, and 90‑day outcomes were collected. Adverse clinical outcomes occurred in 13 patients during this period. Spearman correlation and Firth penalized logistic regression were used. No differences were found between age groups in platelet count or aggregation rates (all P > 0.05). Prothrombin time was longer in the ≥90 group (13.32±1.31 vs. 12.08±1.63 s, P < 0.001). Platelet function showed no meaningful correlation with white blood cell count, hemoglobin, or fibrinogen (|r| < 0.2, all P > 0.05). Among the 94 patients, 13 had poor outcomes. In Firth regression, neither age ≥90 years (OR=2.86, 95% CI: 0.85–9.62, P=0.090) nor coronary heart disease (OR=1.61, 95% CI: 0.50–5.21, P=0.424) reached statistical significance. The model’s area under the ROC curve was 0.657 (bias‑corrected 0.640). In this cohort of very elderly patients not on antiplatelet or anticoagulant therapy, native platelet function did not differ between octogenarians and nonagenarians and showed no correlation with routine hematological parameters. No statistically significant predictor of poor 90‑day outcomes was identified. The small number of outcome events (n=13) limits statistical power, so these findings should be considered exploratory. Larger prospective studies are needed to validate these findings.

  • Effect of ambient temperature changes on the treatment and prognosis in patients with acute stroke receiving intravenous thrombolysis

    by Tianli Zhang, Juanjuan Xue, Xuan Chen, Xiaolong Wang, Xiaoshuang Xia, Xin Li

    We determined whether environmental temperature affects the time delay and clinical outcomes in patients with acute ischemic stroke receiving intravenous recombinant tissue plasminogen activator (rt-PA) thrombolysis. We analyzed patient characteristics, severity of neurological impairment, and functional outcomes at 90 days in a cohort of 1,959 patients (median age, 65 [56-75] years) from the Stroke Emergency Map Registry Center of Taiyuan, Shanxi Province (China), of whom 899 (45.89%) received rt-PA during the cold season. Patients treated during the warm season exhibited a shorter time from onset to door and shorter time from onset to intravenous thrombolysis start. Furthermore, they were more likely to achieve a non-disabled outcome (modified Rankin score [mRS] 0-1) and favorable clinical outcome (mRS 0-2) at 90 days. Although the season did not independently predict the 90-day mortality risk, a rise in temperature significantly reduced the mortality rate only in the cold season. A nonlinear relationship was observed between the mean temperature on the day of stroke onset and neurological function recovery in surviving patients 7 days post-intravenous thrombolysis. When the temperature was approximately 10 °C, neurological recovery was relatively good at 7 days. The cumulative lag effect at 1 day significantly influenced patients' neurological function compared to that at 7 days. We conclude that lower ambient temperatures may be associated with delayed intravenous thrombolysis and poorer functional outcomes in patients with ischemic stroke. Further studies are needed to minimize treatment delays in patients with stroke caused by adverse weather conditions to improve outcomes.

  • Open Access

    Joint association of atherogenic index of plasma and estimated glucose disposal rate with new-onset cardiovascular disease risk in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: a 9-year nationwide prospective cohort study

    by Yuhang Fan, Zhibo Si, Miaomiao Wei, Yumeng Gu, Xin Li

    The atherogenic index of plasma (AIP) and estimated glucose disposal rate (eGDR) are two composite indices derived from routine metabolic measurements and are associated with cardiocerebrovascular disease risk. In individuals with Cardiovascular-Kidney-Metabolic (CKM) syndrome stages 0-3, however, it remains unclear whether joint stratification by these markers helps summarize gradients of cardiovascular disease, heart disease, and stroke risk beyond single-marker assessment. Using data from the China Health and Retirement Longitudinal Study (CHARLS), 5,925 participants without CVD at the start and in CKM stages 0-3 were analyzed. Participants were grouped by median AIP and/or eGDR values. Kaplan-Meier curves and Cox models assessed the link between these indicators and new CVD, heart disease, and stroke cases. Furthermore, both multiplicative and additive interactions between AIP and eGDR were assessed. The predictive value was assessed using the time-dependent Harrell's C index, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). A cohort of 5,925 participants aged 45 years and older (mean age: 57.92 ± 8.52 years) was analyzed, with 54.65% of the cohort being female. During the nine-year follow-up period, 1,467 (24.76%) participants developed incident CVD, including 1,106 (18.67%) with heart disease and 525 (8.86%) with stroke. The high AIP and low eGDR group had the highest risk, with CVD hazard ratios (HRs) of 1.35 (95% CI 1.14-1.59), heart disease HRs of 1.32 (95% CI 1.08-1.62), and stroke HRs of 1.59 (95% CI 1.19-2.12), using the low AIP and high eGDR group as the reference. Neither multiplicative nor additive interaction was statistically significant. The combined application of AIP and eGDR provided a modest improvement in predictive capability for cardiovascular disease, heart disease, and stroke. In individuals with CKM stages 0-3, combined AIP and eGDR stratification captured gradients of cardiovascular risk. The combined application of these indicators may provide modest incremental value for risk stratification within CKM stages, thereby aiding in the identification of high-risk individuals during the early stages of CKM.


  • Open Access

    Z-DNA binding protein 1 mediates heat stress-induced neuronal necroptosis

    by Jin Deng, Yumeng Gu, Yuchen Li, Miaomiao Wei, Lin Wang, Xin Li

  • Open Access

    Cold environment is associated with worse outcomes in ischemic stroke patients and the underlying gut microbial mechanism

    by Chanjuan Wei, Xiao Zhou, Xiaoshuang Xia, Wenjun Feng, Lin Wang, Xin Li

    Background: Increasing evidence suggests that cold environment is a potential risk factor for acute ischemic stroke (AIS) and is associated with poor prognosis, however, its underlying mechanisms remain unclear. Since gut dysbiosis and AIS are causally related and cold environment can induce changes in the gut microbiota, we wondered whether cold-season-related gut dysbiosis aggravates stroke progression. Methods: In total, 101 patients with AIS were enrolled and divided into two groups: cold-season onset ischemic stroke (CIS) and non-cold-season onset ischemic stroke (NCIS). Gut microbiota composition was analyzed using 16 S rRNA gene sequencing, and signature taxa were identified via linear discriminant analysis effect size (LEfSe). Correlations between key microbial taxa and clinical parameters were assessed using Spearman rank analysis. To evaluate the potential causal role of gut microbiota in cold season stroke, fecal microbiota transplantation (FMT) was performed in mice, followed by middle cerebral artery occlusion (MCAO). Results: The composition of gut microbiota in the CIS group significantly differed from the NCIS group. The characteristic microbiota of the CIS group was distinguished by an elevated relative abundance of Escherichia-Shigella and Enterococcus , coupled with a decreased percentage of Blautia , Eubacterium_hallii_group , Subdoligranulum , Dorea , Faecalibacterium , Ruminococcus , and Collinsella . Furthermore, Escherichia-Shigella , Enterococcus , Blautia , Eubacterium_hallii_group and Faecalibacterium showed predictive value for 3-month poor prognosis in patients. Compared with mice inoculated with the NCIS gut microbiota, mice inoculated with the CIS gut microbiota showed more severe brain damage, impaired intestinal barrier function, and higher levels of inflammatory factors after the stroke model was established. Conclusions: Our study indicates that cold-season-related gut dysbiosis may be linked to stroke severity and poor prognosis in AIS patients, suggesting that modulation of gut microbiota could represent a potential avenue for therapeutic intervention.

  • Open Access

    Cold exposure promotes thrombotic risk in ischemic stroke by activating the platelet cGAS-STING pathway

    by Yuchen Li, Miaomiao Wei, Yumeng Gu, Jin Deng, Xiaokun Guo, Lin Wang, Xin Li


  • Open Access

    Effect of the atherogenic index of plasma on the expression of platelet CD36 and CD62P in patients with acute ischemic stroke: a retrospective study from Tianjin, China

    by Yusen Cai, Miaomiao Wei, Yumeng Gu, Lin Wang, Xin Li

    The atherogenic Index of Plasma (AIP) is closely linked to the incidence of acute ischemic stroke (AIS). This study aimed to investigate the effect of AIP on the expression levels of platelet surface markers CD36 and CD62P in AIS patients, and further analyze the correlations among these three indicators. This retrospective study enrolled 441 AIS patients who underwent platelet flow cytometry and were admitted between January 2024 and June 2025. Participants were stratified by AIP tertiles. Platelet CD36 and CD62P expression levels were detected via flow cytometry. Multivariate adjusted regression models and linear regression analyses were performed to explore the relationships between AIP and platelet CD36/CD62P expression. Stratified analyses were conducted by potential risk factors to examine subgroup differences. A generalized additive model (GAM) with smooth curve fitting was used to investigate the association pattern between CD36 and CD62P. Simple mediation analysis via the bootstrap method was applied to explore the potential mediating effect of CD36 in the relationship between AIP and CD62P. AIP, whether considered as a continuous or a categorical variable, was significantly correlated with platelet CD62P levels. For each 1-unit increase in AIP, CD62P levels rose by 1.62 (β = 1.62, 95% CI: 0.41–2.82, P = 0.009). When AIP was divided into tertiles, the highest tertile (Q3) showed a significant increase in CD62P levels compared to the lowest (Q1), with a significant dose-response trend (P < 0.05). AIP also showed a significant positive correlation with CD36 (β = 2.30, 95% CI: 0.43–4.16, P = 0.016), with significant differences in CD36 levels in both middle (Q2) and highest tertiles (Q3) compared to Q1. The GAM with smooth curve fitting showed that higher CD36 expression led to increased platelet CD62P levels (95% CI:11.19–12.87), confirming a significant nonlinear relationship (P = 0.0017). A mediation model indicated that CD36 partially mediates the effect of AIP on CD62P. In AIS patients, high AIP levels are linked to increased platelet markers CD36 and CD62P, as well as dyslipidemia and atherosclerosis. AIP has the potential to serve as a significant biomarker for assessing platelet activity.